Prognostic significance of the p185 protein in colorectal cancer;Significado pronóstico de la proteína p185 en cáncer colorrectal

Revista Espanola de Enfermedades Digestivas

Volumn 96, Issue 2, 2004, Pages 102-109

  Sanz Casla, M T ^a   Vidaurreta, M ^a   Maestro, Ma Luisa ^a   Lopez J A ^a   Jimenez F ^a   Fernandez C ^a   Maestro, C ^b   Balibrea, J L ^a   Cerdan F J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

c cerB 2 neu oncogene; Colorectal carcinoma; p185 protein; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; FOLINIC ACID; PROTEIN P185;

ADULT; AGED; ARTICLE; CANCER STAGING; COLON ADENOCARCINOMA; COLORECTAL CANCER; COLORECTAL SURGERY; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOGENE NEU; PROGNOSIS; PROSPECTIVE STUDY; SURGEON; TUMOR GROWTH;

EID: 1642526530     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082004000200003     Document Type: Article

References (21)

1. Yamamoto T, Ikawa S, Akiyama T, et al. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature 1986; 319: 230-4.
2. Hung MC, Lau YK. Basic science of HER-2/neu: A review. Semin Oncol 1999; 26: 51-9.
3. Lemoine LR, Jain S, Silvestre F, Lopes C, Hughes CM, McLelland E, et al. Amplifiaction and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. Br J Cancer 1991; 64: 79-83.
4. Klapper LN, Kirschbaum MH, Sela M, Yarden Y. Biochemical and clinical implications of the ErbB/HER signalling network of growth factor receptors. Adv Cancer Res 2000; 77: 25-79.
5. Bozzeti C, Nizzoli R, Guazzi A, Flora M, Bassano C, Crafa P, et al. HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast. Ann Oncol, 2002; 13: 1398-403.
6. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707-12.
7. Gusteson BA, Price KN, Gelber RD, Goldhirsch A, Säve-Söderborgh AR, Styles J, et al. Prognostic importance of c-erbB-2 expression in breast cancer. J Clin Oncol 1992; 10: 1049-56.
8. Amadori D, Maltoni M, Volpi A, Nanni O, Scarpi E, Renault B, et al. Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma. Cancer 1997; 79: 226-32.
9. Yonemora Y, Ninomiya I, Tsugawa K, Fushida S, Fujimura T, Miyazaki I, et al. Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach. Cancer Detect Prev 1998; 22: 139-46.
10. Kay EW, Mulcahy H, Walsh CB, Leader M, O'Donoghue D. Cytoplasmic c-erbB-2 protein expression correlates with survival in Dukes'B colorectal carcinoma. Histopathology 1994; 25: 455-61.
11. Kapitanovic S, Radosevic S, Kapitanovic M, Andelinovic S, Ferencic Z, Tavassolo M, et al. The expression of p185 HER-2/neu correlates with the stage of disease and survival in colorectal cancer. Gastroenterology 1997; 112: 1103-13.
12. Osako T, Miyahara M, Uchino S, Inomata M, Kitano S, Kobayashi M. Inmunohistochemical Study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival. Oncology 1998; 55: 548-55.
13. Yokota J, Yamamoto T, Toyoshima K, Terada M, Sugimura T, Battifora H, et al. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet 1986; i: 765-6.
14. McCann A, Dervan PA, Johnston PA, Gullick WJ, Carney DN. c-erbB-2 oncoprotein expression in primary human tumors. Cancer 1990; 65: 88-92.
15. D'Emilia J, Bulovas K, D'Ercole B, Wolf B, Steele G Jr, Summerhayes IC. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. Oncogene 1989; 4: 1233-9.
16. Ohmori K, Uchino J, Kondou Y, et al. Prediction of hepatic metastasis after resection of colorectal carcinoma-From the viewpoint of pathologic features. C-erbB-2 expression and nuclear DNA content. Jpn J Gastroenterol Surg 1991; 24: 2963-9.
17. Cerdán FJ. Seguimiento de los pacientes intervenidos por cáncer colorrectal. Rev Cancer 1997; 11: 32-41.
18. McKay JA, Loane JF, Ross VG, Ameyaw MM, Murray GI, Cassidy J. c-erbB-2 is not a major factor in the development of colorectal cancer. Br J Cancer 2002; 86: 568-73.
19. Webb A, Scott-Mackie P, Cunningham D, Norman A, Andreyev J, O'Brien M. The prognostic value of CEA, beta HCG, AFP, CA125, CA 19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer. Ann Oncol 1995; 6: 581-7.
20. Corbett IP, Henry JA, Angus B, Watchorn CJ, Wilkinson L, Hennessi C, et al. NCLA-CB 11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncoge protein effective for use on formalin-fixed, paraffin-embedded tissue. J Pathol 1990; 161: 15-25.
21. Cerdán J. Recidiva locorregional en el cáncer de recto. Cir Esp 2003; 73: 63-7.